Konig et al. found that PPARα activation by synthetic agonist clofibrate and by fasting increased mRNA concentration of MCT1 in the liver of rats and in rat hepatoma cells treated with WY14,643 (another selective PPARα agonist) [44]. This evidence concerns the gene PPARA and hepatocellular carcinoma.